Travere Therapeutics, Inc. (TVTX)
52.12
+0.08
(+0.16%)
USD |
NASDAQ |
Oct 09, 16:00
52.17
+0.04
(+0.09%)
After-Hours: 20:00
Travere Therapeutics 30-Day Average Daily Volume : 1.702M for Oct. 9, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.702M |
| October 08, 2026 | 1.693M |
| October 07, 2026 | 1.679M |
| October 06, 2026 | 1.615M |
| October 05, 2026 | 1.546M |
| October 02, 2026 | 1.512M |
| October 01, 2026 | 1.490M |
| September 30, 2026 | 1.461M |
| September 29, 2026 | 1.438M |
| September 28, 2026 | 1.438M |
| September 25, 2026 | 1.437M |
| September 24, 2026 | 1.439M |
| September 23, 2026 | 1.415M |
| September 22, 2026 | 1.401M |
| September 21, 2026 | 1.356M |
| September 18, 2026 | 1.344M |
| September 17, 2026 | 1.365M |
| September 16, 2026 | 1.529M |
| September 15, 2026 | 1.537M |
| September 14, 2026 | 1.531M |
| September 11, 2026 | 1.557M |
| September 10, 2026 | 1.553M |
| September 09, 2026 | 1.539M |
| September 08, 2026 | 1.535M |
| September 04, 2026 | 1.546M |
| Date | Value |
|---|---|
| September 03, 2026 | 1.551M |
| September 02, 2026 | 1.567M |
| September 01, 2026 | 1.561M |
| August 31, 2026 | 1.559M |
| August 28, 2026 | 1.521M |
| August 27, 2026 | 1.544M |
| August 26, 2026 | 1.561M |
| August 25, 2026 | 1.547M |
| August 24, 2026 | 1.527M |
| August 21, 2026 | 1.527M |
| August 20, 2026 | 1.514M |
| August 19, 2026 | 1.526M |
| August 18, 2026 | 1.527M |
| August 17, 2026 | 1.540M |
| August 14, 2026 | 1.550M |
| August 13, 2026 | 1.567M |
| August 12, 2026 | 1.576M |
| August 11, 2026 | 1.622M |
| August 10, 2026 | 1.625M |
| August 07, 2026 | 1.729M |
| August 06, 2026 | 1.778M |
| August 05, 2026 | 1.765M |
| August 04, 2026 | 1.607M |
| August 03, 2026 | 1.583M |
| July 31, 2026 | 1.739M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| TG Therapeutics, Inc. | 1.816M |
| BioMarin Pharmaceutical, Inc. | 2.102M |
| Vertex Pharmaceuticals, Inc. | 1.034M |
| Viridian Therapeutics, Inc. | 1.741M |
| Krystal Biotech, Inc. | 280311.5 |